Objective: To assess independently, paired patient (PT) and PT-selected significant other (SO) perceptions of the impact on glucose management and lifestyle of continuous subcutaneous insulin infusion (CSII) and multiple daily insulin injections (MDII) during intensive diabetes management (IDM). Methods: Four newly developed, parallel PT and SO survey instruments (CSIIpt and MDIIpt; CSIIso and MDIIso), based on Socio-Technical Systems Theory and the Life Patterns Model, were used to elicit demographic information and perceptions. Results: Both PTs and SOs rated CSII higher (p<.001) than MDII concerning PT perceived impact on disease management and lifestyle. SOs evaluating the impact of PT treatment method on their own lifestyles reported no difference. Of dependent variables and interactions examined, only "treatment method" and "age group" had significant effects: Increased age was positively associated with PT perceived impact on disease management and lifestyle for both CSII and MDII. Conclusions: Both CSII and MDII are effective IDM methodologies, but PTs perceive CSII more positively, suggesting CSII's greater potential for long-term compliance. Neither PT age nor formal education level achieved contraindicates choosing CSII for IDM. No other factor examined (diabetes type, gender, race, income level, employment status) predicts treatment method-associated perceived disease management or lifestyle impact during IDM.
Introduction
The number of people with Diabetes Mellitus (DM) worldwide is projected to increase from 387 million in 2014 to more than 590 million by 2035 (IDF, 2014) . A major cause of premature death and illness (IDF, 2012) , more than 80% of DMrelated deaths occur in low-and middle-income countries (WHO, 2011) . Globally, 471 billion US$ were spent in 2012 due to DM (IDF, 2012) .
In the United States, (a) 29.1 million people had either diagnosed or undiagnosed DM, (b) the disease cost Americans $245 billion in 2012, (c) average annual medical expenditures for people with DM were 2.3-fold higher than for people without DM, and (d) DM is the 7 th leading cause of death and a major cause of heart disease, stroke, new adult blindness, kidney failure, and non-traumatic lower extremity amputations (ADA, 2014) . Although the rates of DM-related complications decreased substantially from 1990 to 2010, the large disease burden persisted because of continually increasing DM prevalence (Gregg, Li, Wang, Burrows et al., 2014) .
Two years following initiation of insulin therapy (but not intensive diabetes management (IDM)), glycosylated hemoglobin (HA1c) levels exceed 8% in 60% of people with Type 2 DM (Koro, Bowlin, Bourgeois & Fedder, 2014) , but IDM protocols can maintain near normal ambulatory blood glucose levels (DCCT, 1993; Nathan, Cleary, Backlund, Genuth et al., 2005; Holman, Paul, Bethel, Matthews & Neil. 2008) . By facilitating glucose control, IDM can reduce the system cost of DM care by avoiding acute and minimizing long-term complications while encouraging IDM program compliance by improving quality of life (Chantelau, Schiffers, Schutze & Hensen, 1997; Barnard & Skinner, 2008; Urzúa, Bravo, Ogalde & Vargas, 2011) .
IDM is labor intensive (AHRQ, 2012) , and tight glucose control can increase risk of hypoglycemia (Nathan, Cleary, Backlund, Genuth et al., 2005) . Published guidelines (NIHCE, 2014) can help select the appropriate IDM method and guide education, follow-up protocols, or specialist referral as needed (Bode, Sabbah, Gross, Fredrickson & Davidson, 2002) .
It is important to note, however, that individuals without access to specialty care tend not to achieve adequate DM control (Andrus, Kelly, Murphey & Herndon, 2004; Bellinger, Hassan & Rivers, 2010; Chen, Huang, Peng, Jong et al., 2011) , but systematically shared primary and specialty responsibilities can deliver effective care (Smith, Allwright & O'Dowd, 2007; Smith, Allwright & O'Dowd, 2008) . 3 IDM requires patient (PT) recognition of continuous management responsibilities (insulin, diet, activity, glucose monitoring) (Hoogma, Spijker, van Doorn-Scheele, van Doorn et al., 2004; Bradley, de Pablos-Velasco, Parhofer, Eschwège et al., 2011 ) that usually require lifestyle changes. Ongoing PT ownership and commitment, facilitated by family and significant other (SO) support, are essential for successful outcomes and HA1c levels at/below 7% (Koro, Bowlin, Bourgeois & Fedder, 2014 (AHRQ, 2012) , and IDM of any type can impact quality of life beneficially (Pouwer & Hermanns, 2009; Urzua, Shirino & Valladares, 2011) . However, while one third of PTs using MDII fail to achieve the HA1c goal (Holmann, Farmer, Davies, Levy et al., 2009) , considerable evidence supports the effectiveness of CSII in adults (Edelmann, Walter, Biermann, Schleicher et al., 1987; Rubin & Peyrot, 2009; Reznik, Morera, Rod, Coffin et al., 2010) , including individuals with Type 2 DM (Raskin, Bode, Marks, Hirsch et al., 2003; Fatourechi, Kudva, Murad, Elamin et al., 2009; Lynch, Riedel, Samant, Fan et al., 2010) . Although declining vision, dexterity, and cognition must be considered in older individuals (Stephens & Jeffner, 2010) , a Diabetes Technology Society consensus recommended that CSII be considered across all age groups (Klonoff & Reyes, 2009 ). Our study's conceptual framework is based on Socio-Technical Systems Theory (STST) and the Life Patterns Model (LPM) which postulate that personal behavior changes are influenced by social and technical aspects of the lives of individuals and their SOs (Emery & Trist, 1960; Fox, 1995) . The relevant sociocultural system in this study included roles, relationships, support groups, selfesteem, use of time, and life structure (daily routines). The technical system, MDII or CSII, included tools, techniques, procedures, knowledge, and devices employed monitoring and managing DM (Stachura, Rosenkoetter, Wood, Dias & Brown, 2011) .
We hypothesized differences in the perceptions of CSII and MDII by both PTs and their paired SOs regarding IDM method impact on both DM management and life patterns. 
Methods

Study Tools
Four parallel survey instruments (CSIIpt; CSIIso; MDIIpt; MDIIso) were based on STST, constructed using Tailored Design Methods (Dillman, Smyth & Christian, 2009 ) and tested for reliability and validity (Rosenkoetter, Stachura, Dias, Wood & Brown, 2014) .In each survey instrument: Section I identified the subject's demographic characteristics, social setting, healthcare sources, insurance, and IDM methodology (CSII or MDII) used; Section II (18 five-point Likert-type items) assessed perceptions of IDM method effect on life patterns; Section III (25 five-point Likerttype items) assessed perceptions of the IDM method used, after switching to MDII or CSII from previous insulin administration methods; Section IV (2 five-point Likerttype items) assessed overall perceptions of CSII or MDII effects on satisfaction with impact on lifestyle and/or DM management; Section V (only on MDIIpt survey instruments) asked ten True/False questions about why PTs were not using CSII. Cronbach's alpha score for each of the instruments exceeded 0.9, indicating "excellent" internal consistency. Calculated instrument reading levels were compatible with PT-and SO-reported education levels (high school graduation: CSII 99%; MDII 96%) (Rosenkoetter, Stachura, Dias, Wood & Brown, 2014) .
Power and Sample-Size Calculations
Definitive power and sample-size analysis were not possible because no normative data existed for the major outcome variables of this study in the subject population. Anticipated sample sizes allowed projected detection of relatively small to moderate standardized effect sizes with at least 80% power at the alpha=0.05 level of significance. With respect to identifying areas in which aggressive management and lifestyle issues should be pursued and monitored, projected detectable effect sizes were between 0.3 and 0.4 SD (Rosenkoetter, Stachura, Dias, Wood & Brown, 2014) .
Participant Recruitment
PTs were recruited from university clinics, participants in other university clinical research projects who previously consented to future contact, practices of former university Endocrinology fellows, and non-university community clinics. All were Institutional Review Board (IRB) approved.
Male or female candidate inclusion criteria included age at or above 18 years, ability to read and/or speak English, diagnosed with Type 1 or Type 2 DM, using an MDII (minimally 3 daily injections) or CSII regimen (minimally 3 months), and willing to identify a SO (spouse, family member, co-worker, friend) familiar with the PT's DM and a frequent participant in PT thinking about DM management and consequences. Pregnancy, severe active retinopathy, and debility from impaired renal, hepatic or cardiac function were exclusion criteria. Independently consented SO participants, self-reporting an ability to read and/or speak English, were selected by and paired with PT candidates. Consented PTs and SOs were informed that available $25 gift cards would be awarded, but only after both returned completed study instruments. The university IRB approved all phases of the 3-year study (#0807002).
Statistical Methods
Survey instrument Section II and Section III scores were calculated separately as the average of all item responses. A Total Section II/III score also was calculated. Scores could range from 1 (lesser satisfaction) to 5 (greater satisfaction).Analysis of variance (ANOVA) was used to assess score (Section II, Section III, and Total) differences for PTs and for SOs. The primary factor of interest was IDM Method. The other factors included in the ANOVA were type of PT's DM, Age, Gender, Race, Education, Income, and Employment Status (Table 1) . First-order interactions of IDM Method with each of the other factors were included in the ANOVA model. Wilcoxon's Rank-Sum test was used to compare Method medians for selected PT and SO items that reflected the LPM, and to compare PT and SO Method medians for the two Section IV items -(i) overall satisfaction with the current Method of diabetes management and (ii) the impact of the current Method on lifestyle. Table 2 summarizes the demographic characteristics of consented PTs and their paired SOs for both IDM methods. There were 354 responding pairs (255 CSII, 99 MDII), but "group totals" do not match the 354 total because "Prefer not to specify" was a response option.
Results
Demographics of Study Participants
Of responding CSII PTs: 243 (95.3%) had Type 1 and 12 (4.7%) Type 2 DM, a distribution that reflected insurance coverage for CSII use (CMMS, 2004; CMS, 2007; NCSL, 2011) . Of responding MDII PTs: 56 (56.6%) had Type 1 and 43 (43.4%) Type 2 DM.
Respondent distribution by age group (see Table 1 ) was similar, although MDII outnumbered CSII in PTs older than 50, again consistent with expectations based on insurance coverage of CSII use in older populations.
Female PTs comprised the majority for both CSII (n=165,64.7%) and MDII (n=55,55.6%).
Most patients were White (CSII n=228, 89.4%; MDII n=72,72.7%). No identified income level was unrepresented, and most PTs reported at least high school graduation match their own.
ANOVA Results
The reported mean (parentheses) ANOVA results are estimated marginal means (least-squares estimated means adjusted for all model terms).
ANOVA Results for PTs
PT Survey Total Scores
There were significant (p<0.001) Method (CSII vs. MDII) differences for Total Scores: CSII PTs reported greater over-all satisfaction (4.07) than did MDII PTs (3.58).
Satisfaction differed with age (p=0.013): Increasing satisfaction was associated with increasing age -Younger (3.70), Middle (3.78), Older (4.00).
No other factors or interactions were significant. Method -CSII PTs (4.01) reported greater satisfaction (p<0.001) than did MDII PTs (3.56). Satisfaction differed with age (p<0.001): Increasing satisfaction was associated with increasing age -Younger (3.64), Middle (3.72), Older (3.99).
PT Survey Section II (perceived IDM effect on life pattern) Scores:
No other factors or interactions were significant.
PT Survey Section III (perceptions of IDM method after change from previous method) Scores:
Method -CSII PTs (4.11) reported statistically significant greater (p<0.001) satisfaction than did MDII PTs (3.59).
Although there were no statistically significant different (p=0.113) Section III Age CSII scores, there was a trend of increasing satisfaction being associated with increasing age -Young (3.73), Middle (3.81), Older (4.00), similar to that seen in Section II scores.
ANOVA Results for SOs
SO Survey Total Scores:
Method -CSII SOs reported statistically significant greater (p=0.046) satisfaction (3.48) than MDII SOs (3.29).
Income -Effects were statistically significant (p=0.011): Low(3.39), Middle (3.21), High(3.54).
No other factors or interactions were significant except Income (see below).
SO Survey Section II Scores:
Method -CSII SOs (3.32) reported statistically significant greater (p<0.017) satisfaction than MDII SOs (3.10).
SO Survey Section III Scores:
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Method -There was no significant (p=0.056) difference for Section III scores, but there was a trend with CSII SOs (3.64) reporting greater satisfaction than did MDII SOs (3.42).
Income -There were statistically significant (p=0.012) differences in Section III scores: Low (3.52), Middle (3.34), High (3.74).
No other factors or interactions were statistically significant except Income (see below).
Method-by-Income Interaction for SOs:
SO Survey Total Scores:
Method-by-Income interaction was statistically significant (p=0.017). While CSII, means for all three income categories (see Table 1 ) were approximately 3.5, MDII income category means were Low (3.29), Middle (2.97), and High (3.60) and statistically significant (p=0.017).
SO Survey Section III Scores:
Method-by-Income interaction: While CSII means for the three income categories were similar (~3.7), MDII, income category means were Low (3.42), Middle (3.03), and High (3.80).
Wilcoxon's Rank-Sum Results
Method -For both PT and SO surveys and for both Section IV items (CSII or MDII effects upon PT and SO satisfaction with impact on lifestyle and diabetes management), there were significant differences (p<0.001).
Both PTs and SOs reported greater overall satisfaction with the impact of CSII (median=4) on management of diabetes than with MDII (median=3).
Both PTs and SOs also reported greater overall satisfaction with impact of CSII (median=4) on lifestyle than with MDII (median=3). There were statistically significant (p<0.015) Method differences for CSII (median=5) compared to MDII (median=4) for the questions: "The insulinpump/multiple-daily-injections does/do not interfere with my activities of daily living"; "I am more independent with the pump/multiple-daily-injections than before I began using it/started using this routine"; "Activities outside my home are easier to manage now that I am using an insulin pump/taking multiple daily injections"; "I have more flexibility with my activities". Differences were not found with the questions "I miss fewer days at work"; "I participate more in family activities"; "I participate more in outside activities". Table 3 (lower portion) provides responses to selected parallel survey items reflective of the LPM for CSII and MDII SOs. There were statistically significant (p<0.042) Method differences for CSII (median=4) compared to MDII (median=3) for the questions: "Activities of daily living are easier for me to perform now that he/she has an insulin pump/began using multiple daily insulin injections"; "I am more independent than before he/she began using the insulin pump/multiple daily insulin injections"; "Activities outside my home are easier for me to manage now that he/she is using an insulin pump/taking multiple daily insulin injections"; "I have more flexibility with my activities". Differences were not found for "I miss fewer days at work"; "I participate more in family activities"; "I have more flexibility with my activities". 
Survey Section V Results
Section V sought information about why MDII patients were not using CSII and was included on patient MDII survey instruments only. Total responses for each question do not equal 99(the MDII n=99 total) because some patients elected not to answer some Table 4 questions.
Table 4: Section V responses for MDII patients (n=99)
Item
True/False "I have never heard of an insulin pump" 8/88 "No one has explained an insulin pump to me" 22/73 "My primary provider has not told me about an insulin pump" 24/69 "I am afraid of technology like an insulin pump" 17/76 "My insurance will not cover an insulin pump" 29/52 "I have been told that I am not a good candidate for an insulin pump" 14/79 "I live too far from my provider's office to receive insulin pump care" 3/88 "An insulin pump would take too much of my time to care for" 28/63 "I do not want an insulin pump" 52/42
Discussion
We explored whether using either MDII or CSII for IDM resulted in PT-or SO-perceived advantage, even though either management method can enable PTs to achieve glucose control. Such a perceived differential impact on disease management and/or PT lifestyle could impact long-term self-management practices and success in general or for identifiable subgroups such as active and engaged individuals (Raskin, Bode, Marks, Hirsch et al., 2003) or older adults (Rosenkoetter, Stachura, Dias, Wood & Brown, 2013) .
Our inclusion criteria intentionally defined a unique set of PTs: All were already practicing IDM using either MDII or CSII. Patients committing to IDM are highly motivated, and those who persist in the use of either MDII or CSII demonstrate both high organizational skills and self-responsibility for disease management. It was not surprising, therefore, that almost all participating patients reported completing at least high school education.
We aimed to capture a group of PTs who had been sufficiently dissatisfied with "usual care" to be willing to explore, comprehend, commit to, and execute the self-responsibilities required for successful IDM. Further, because actively practicing IDM for a defined minimum time period was also an inclusion criterion, these PTs presumably were more satisfied with whichever IDM they used, than they had been with "usual care".
We purposefully did not collect objective data such as HA1c or mean glucose values to sub-group participants; we were not attempting to duplicate previous studies of MDII and CSII effectiveness for normalizing blood glucose levels.
We hypothesized that differences in perceived impact on disease management and lifestyle among motivated PTs using one of two IDM methods (MDII and CSII) could influence whether these PTs would sustain IDM activities long enough to achieve the benefits of glucose control. Although better glucose control may have been an initial motivator for PTs to pursue IDM, we also hypothesized that the human cost of maintaining the particular IDM method compared to the perceived lifestyle benefits it conferred would define satisfaction.
We also explored whether PT efforts at IDM would be reinforced if the SOs with whom they regularly shared thoughts about DM and its consequences confirmed their impact perceptions, whether or not the SOs identified similar indirect benefits for themselves.
Not surprisingly, both MDII and CSII PTs perceived greater impact of their IDM method on disease management and lifestyle than previous "usual care" protocols had produced. CSII PTs, however, perceived significantly greater impact than did MDII PTs, as shown by lifestyle (Section II), management (Section III), and Total (Section II+III) scores. Surprisingly, perceived impact increased with age among both MDII and CSII PTs, with the highest scores reported for CSII among those aged over 60 years. On the other hand, no such effect of PT gender, race, educational level, income, employment status, or DM type was demonstrable.
Similarly for SOs, both Section II (impact on lifestyle) and Total (impact on lifestyle and IDM) scores were significantly higher for CSII than for MDII, and although SO Section III (management) scores did not achieve statistical significance, CSII scores trended higher than MDII scores. We speculate that the lack of statistical significance for SOs in Section III (impact on IDM) may result from most SOs not being as closely involved in day-to-day disease management as are PTs.
In contrast to PT scores, there was no SO age effect, most likely because PTs frequently did not choose SOs whose age matched their own, and as with PTs, there was no effect of diabetes type, gender, race, educational level, income level, or employment status.
Over-all PT and SO perceived CSII satisfaction with impact (Survey Section IV -impact on IDM change) scores were higher than MDII scores for both disease management and lifestyle, but perceived impact Section II and Section III scores revealed an important difference (Table 3) . Whereas CSII consistently and with statistical significance outscored MDII on issues of both disease management and the ease with which life activities are integrated with the IDM protocol used, there was no difference between CSII and MDII with respect to PT and SO behavior with family, social groups, or the workplace. In other words, while these highly motivated IDM PTs and their SOs discerned a difference in the ease with which they could integrate MDII and CSII into their lives, they would not allow either their disease or the effort required for its management to interfere with the conduct of their lives or their relationships with people important to them. Table 4 , barriers limiting CSII use in Type 2 DM include lack of patient knowledge about CSII, CSII's complexity, concern about lifestyle interruptions, misinformation, and cost (Bode, Sabbah, Gross, Fredrickson & Davidson, 2002) , but initial concerns that CSII patients might experience decreased life quality appear unfounded (Hoogma, Spijker, van Doorn-Scheele, van Doorn et al., 2004) . Our results confirm other reports that given the choice (Table 4) , many patients prefer CSII over MDII (Gentry, Cross, Ross, McFarland & Bestermann, 2011) , given the choice.
As documented in
The over-all cost of implementing and maintaining IDM is complex. An early study suggested that while reducing costs of complications, IDM could increase per patient treatment costs compared with conventional management (Gray, Raikou, McGuire, Fenn et al., 2000) . A more recent study of relationships between glycemic control and medical costs determined that direct medical costs related to Type 2 DM were 16% lower for good versus fair and 20% lower for good versus poor control (Oglesby, Secnik, Barron, Al-Zakwani & Lage, 2006) .
In the US, insurance coverage for CSII varies by state program, insurance carrier and qualifying specifications, (NCSL, 2011) . CSII is an optional and additional coverage for Medicare recipients with Type 2 DM, and approval requires a blood Cpeptide level characteristic of Type 1 DM and unlikely in Type 2 DM (CMMS, 2004; CMS, 2007; Ko, So, Tong, Chan et al., 2009 ). The requirement effectively excludes CSII coverage for Americans aged 65 years and older, those with the highest percentage (26.9%; 10.9 million) of affected individuals and those where Type 2's predominance over Type 1 DM is most pronounced (National Diabetes Fact Sheet, 2011) Our finding that both PTs and their SOs perceive CSII to more successfully integrate IDM into daily living than does MDII (thereby encouraging compliance, promoting healthy lifestyles, and maintaining glucose control), supports reconsideration of policies and regulations that limit CSII use.
This project focused on the use of MDII and CSII. It was limited by the use of a relatively small sample size from one geographical region and the fact that no attempt was made to include clinical data. An expanded study involving a more heterogeneous population sub-grouped by level of management success could refine the profiles of patients expected to succeed with IDM. Our model, however, is generic, and could be used to ask similar questions about other chronic conditions characterized by physician-directed long-term patient self-management protocols employing valuable, but potentially intrusive, technologies.
Conclusions
Among patients who committed to pursue IDM, CSII more positively impacted disease management and lifestyle than MDII according to both patients and the SOs with whom they consistently interact about their disease.
CSII's more positive perception was present across all age groups, including seniors. Neither age nor level-of-education achieved are contraindications to employing CSII for IDM. Neither diabetes type, age, gender, race, education, income, existing health insurance, living circumstance drive the choice of CSII or MDII when recommending an IDM protocol. However, clinicians recommending IDM should be aware that while both MDII and CSII are potent methodologies for achieving glucose control, CSII produces greater patient satisfaction with impact on disease management and lifestyle, and is therefore more likely to positively support long-term compliance.
Anecdotal Study Observations
Clinical
Although DM management is perceived to be improved by using IDM with either CSII or MDII, fear of hypoglycemia resulting from previous severe episode is not allayed. Both PTs and SOs remain anxious about a repetition. The experience of a severe hypoglycemia event is not forgotten; it creates caution about tight management goals.
Educational
A significant proportion of SOs were unaware of how to suspend insulin pump function in the event they found the PT in a state of lessened cognition or even coma, potentially due to hypoglycemia. An even larger proportion of PTs did not believe their own SOs possessed this important knowledge. PTs and SOs should both be included in teaching sessions about basic insulin pump controls and risks of hypoglycemia.
Social
In several instances, PTs who were positive about CSII-improved lifestyle and independence were noted to be paired with SOs who were displeased with the impact of PT IDM on themselves. In each of these instances, the SO self-identified as "husband".
Apparently, while use of CSII for IDM increased PT independence and ability to become involved in life activities, that independence was perceived by the SO to negatively impact the couple's relationship. Unanticipated secondary effects of otherwise beneficial interventions can have unfortunate consequences.
